(2026 Guide) In the realm of weight-loss treatments, there are a handful of major players that people invest in to get into better shape
Coverage and accessibility is definitely going to be the biggest challenge as we move forward in treating people with obesity. Benefits beyond weight loss In August, Novo Nordisk, the maker of Ozempic and Wegovy, became the first to demonstrate in a large clinical trial that the drugs provide health benefits beyond weight loss and diabetes management
Pulmonary aspiration: Pulmonary aspiration occurs when a patient inhales food or liquid from the stomach into the lungs
However, significant metabolic changes that occur during treatmentparticularly substantial weight losscould theoretically affect menstrual patterns
Semaglutide, other obesity drugs show potential to treat nondiabetic stroke GLP-1 receptor agonists such as semaglutide may be able to help reduce the risk of ischemic stroke in patients without diabetes, according to a new meta-analysis of preclinical studies published in Stroke .[1] These drugs have been linked to several key improvements in the cardiovascular health of patients with type 2 diabetes
